Neuronostics

Neuronostics is developing digital biomarkers to unlock the greater potential of EEGs (electroencephalograms) and improve neurological care. Its technology analyses patterns in background brain activity to provide additional information alongside conventional EEG interpretation to support clinical decision-making. Its first product, BioEP, focuses on epilepsy, helping clinicians get more value from routine EEGs, even when results appear inconclusive.